Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell ACADIA Pharmaceuticals Inc. (ACAD) – ACADIA Pharmaceuticals Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ACADIA Pharmaceuticals (ACAD) trades at $21.10, down 1.03% on the day, with a bearish technical signal from moving averages. The company reported strong revenue growth, with 2025 revenue reaching $1.07 billion and net income of $391 million, though Q1 2026 earnings missed estimates. Analyst consensus remains bullish with a $32.11 price target, supported by a $1 billion brand opportunity highlighted at recent conferences. Cash flow turned negative in 2025 due to significant investing outflows.
The outlook for ACAD is mixed; robust profitability and analyst optimism contrast with recent earnings miss and bearish technicals. Key opportunities include neuropsychiatry data readouts and product expansion, while risks involve execution on clinical milestones and sustained negative cash flow. The stock presents a potential upside based on fundamentals if near-term operational challenges are overcome.
Read full analysis

Key Stats

  • Market Cap
    $3.61B
  • Sector
    Health
  • 3M Drawdown
    -18.78%
  • Enterprise Value
    $2.81B
  • Dividend Yield
    -
  • Typical Hold Time
    74 days
$21.1
52W Low: $20.06
13 Oct 2025
52W High: $28.06
22 Dec 2025

ACADIA Pharmaceuticals Inc. (ACAD) is currently valued at a market capitalization of $3.61B, with an enterprise value of $2.81B. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $20.06 and a high of $28.06, highlighting its annual price range. Over the past three months, ACADIA Pharmaceuticals Inc. has recorded a drawdown of -18.78%, reflecting recent price volatility. On average, investors hold ACADIA Pharmaceuticals Inc. for approximately 74 days, indicating typical investor behavior on the platform.

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $3.61B
  • Sector
    Health
  • 3M Drawdown
    -18.78%
  • Enterprise Value
    $2.81B
  • Dividend Yield
    -
  • Typical Hold Time
    74 days
$21.1
52W Low: $20.06
13 Oct 2025
52W High: $28.06
22 Dec 2025

ACADIA Pharmaceuticals Inc. (ACAD) is currently valued at a market capitalization of $3.61B, with an enterprise value of $2.81B. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $20.06 and a high of $28.06, highlighting its annual price range. Over the past three months, ACADIA Pharmaceuticals Inc. has recorded a drawdown of -18.78%, reflecting recent price volatility. On average, investors hold ACADIA Pharmaceuticals Inc. for approximately 74 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!